News
FMS
20.36
-1.95%
-0.41
FDA: IDENTIFIED FRESENIUS MEDICAL CARE'S RECALL OF STAY-SAFE CATHETER EXTENSION SETS & STAY-SAFE/LUER LOCK ADAPTER AS A CLASS I RECALL
Reuters · 5h ago
FDA SAYS FRESENIUS MEDICAL CARE RECALLS STAY-SAFE CATHETER EXTENSION SETS AND STAY-SAFE/LUER LOCK ADAPTER
Reuters · 5h ago
FDA: FRESENIUS MEDICAL CARE'S STAY-SAFE CATHETER EXTENSION SETS & STAY-SAFE/LUER LOCK ADAPTER RECALLED DUE TO HIGHER THAN ALLOWABLE LEVELS OF NDL-PCBA
Reuters · 5h ago
March's Dividend Portfolio Update Sets New All-Time Record - 100 Holdings, 21 Buys
March's Dividend Portfolio Update Sets New All-Time Record - 100 Holdings, 21 Buys. Global stock indices continued an upward trend in March, with both U.S. Stocks rising by 3%. Nvidia unveiled its groundbreaking Blackwell chip at GTC 2024. The S&P 500 recorded its longest positive monthly streak since 2021.
Seeking Alpha · 6h ago
Doctors perform first combined heart pump and pig kidney transplant surgery
Seeking Alpha · 1d ago
Ryder beats Q1 estimates, provides FY 2024 forecast
Ryder beats Q1 estimates, provides FY 2024 forecast. Q1 non-GAAP EPS of $2.14 beats by $0.43. Revenue of $3.1B (+3.3% Y/Y) up 6%. Full-Year 2024 forecast ROE of 15.5% - 16.5%.
Seeking Alpha · 2d ago
Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday
Shares of Matterport, Inc. Rose sharply during Monday's session. The Nasdaq Composite gained over 100 points on Monday. Matterport shares climbed 184% to $4.93. Graphjet Technology's stock surged 27.6% amid a rise in Bitcoin. Other big stocks recording gains in today's session include MicroStrategy and Sea Limited.
Benzinga · 3d ago
Weekly Report: what happened at FMS last week (0415-0419)?
Weekly Report · 3d ago
Bank of America Securities Sticks to Its Sell Rating for Fresenius Medical Care (FMS)
TipRanks · 6d ago
J.B. Hunt shares negative as Q1 profit, revenue misses expectations
Seeking Alpha · 04/16 20:44
BRIEF-Fresenius Accelerates Momentum In Its (Bio)Pharma Business And Launches TYENNE®
Fresenius Accelerates Momentum In Its (Bio)Pharma Business And Launches TYENNE® April 15. German company launches its third approved biosimilar in the U.S. For use in Europe and the Middle East. The company is a subsidiary of Fresenius Medical.
Reuters · 04/15 15:07
Weekly Report: what happened at FMS last week (0408-0412)?
Weekly Report · 04/15 09:11
Comfort Systems USA and Boeing have been highlighted as Zacks Bull and Bear of the Day
NASDAQ · 04/12 12:29
Reasons to Retain Fresenius Medical (FMS) in Your Portfolio Now
NASDAQ · 04/10 13:36
European losers of higher financing costs - JPMorgan
J.P.Morgan analysts published a list of European companies that would suffer due to higher financing costs. According to a Global Markets Strategy report, if bond yields move further up, the market will weaken like it did last summer. The report published a basket of highly leveraged companies that could be the European losers.
Seeking Alpha · 04/08 13:41
Weekly Report: what happened at FMS last week (0401-0405)?
Weekly Report · 04/08 09:11
Weekly Report: what happened at FMS last week (0325-0329)?
Weekly Report · 04/01 09:11
Paragon 28, Inc. (FNA) Moves 16.2% Higher: Will This Strength Last?
NASDAQ · 03/28 08:58
Fresenius Medical (FMS) to Unveil Training on Augmented Reality
NASDAQ · 03/25 15:10
Weekly Report: what happened at FMS last week (0318-0322)?
Weekly Report · 03/25 09:11
More
Webull provides a variety of real-time FMS stock news. You can receive the latest news about Fresenius Med Cr through multiple platforms. This information may help you make smarter investment decisions.
About FMS
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.